Abbott Ordered to Pay $495 Million in Infant Formula Lawsuit

Jury finds Abbott's formula caused severe illness; Reckitt Benckiser shares also impacted by ruling

Abbott must pay $495 million after a jury ruled its formula led to a dangerous bowel disease in an infant.
The lawsuit was brought by an Illinois mother whose daughter developed necrotizing enterocolitis after using the formula.
Abbott and Reckitt Benckiser face nearly 1,000 similar lawsuits in the U.S. over their infant formulas.
Abbott's and Reckitt Benckiser's stock prices dropped significantly following the verdict.
Both companies deny the allegations and plan to appeal the court's decision.